Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Patellofemoral Pain
NCT00496964Phase 3Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- May 2005
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in patellofemoral pain syndrome (PFPS), sponsored by Virginia Commonwealth University. Started May 2005; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
patellofemoral pain syndrome (PFPS)
Beyond the preview
Go deeper on NCT00496964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496964.